# “Guidance for Industry: Assessing Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection;” Availability; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice; correction.
The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of June 30, 2005 (70 FR 37863). The document announced the availability of a guidance document entitled “Guidance for Industry: Assessing Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection.” The document published with inadvertent errors. This document corrects those errors.
**FOR FURTHER INFORMATION CONTACT:**
Joyce Strong, Office of Policy and Planning (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.
**SUPPLEMENTARY INFORMATION:**
In FR Doc. 05-12960, appearing on page 37863 in the *Federal Register* of Thursday, June 30, 2005, the following correction is made:
1. On page 37864, in the second column, under the section heading “ *II. Paperwork Reduction Act of 1995* ”, the second sentence is corrected to read: “The collection of information in this guidance for 21 CFR 601.12 was approved under OMB control number 0910-0338; § 606.170(b) (21 CFR 606.170(b)) has been approved under OMB control number 0910-0116; and § 606.171 has been approved under OMB control number 0910-0458.”
Dated: July 8, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.